DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이해신 | ko |
dc.contributor.author | 신미경 | ko |
dc.contributor.author | 김기석 | ko |
dc.contributor.author | 이향애 | ko |
dc.contributor.author | 박순현 | ko |
dc.date.accessioned | 2024-05-16T08:00:38Z | - |
dc.date.available | 2024-05-16T08:00:38Z | - |
dc.identifier.uri | http://hdl.handle.net/10203/319380 | - |
dc.description.abstract | The present invention relates to a cardiac targeting agent comprising tannic acid, which, by TANNylating a heart disease therapeutic agent to be delivered to the heart, provides the heart disease therapeutic agent with the ability to bind to the cardiac myocardium, thus enabling cardiac targeting and accumulation of the therapeutic agent, wherein the therapeutic agent can be targeted to the heartwith high efficiency even via non-invasive intravenous administration alone, unlike conventional invasive methods used to target therapeutic agents to the heart. | - |
dc.title | Cardiac targeting agent comprising tannic acid | - |
dc.title.alternative | 탄닌산을 포함하는 심장 표적화제 | - |
dc.type | Patent | - |
dc.type.rims | PAT | - |
dc.contributor.localauthor | 이해신 | - |
dc.contributor.nonIdAuthor | 김기석 | - |
dc.contributor.nonIdAuthor | 이향애 | - |
dc.contributor.nonIdAuthor | 박순현 | - |
dc.contributor.assignee | KAIST, Korea Reserch Institute Of Chemical Technology | - |
dc.identifier.iprsType | 특허 | - |
dc.identifier.patentApplicationNumber | 201980021292.8 | - |
dc.identifier.patentRegistrationNumber | 111971067 | - |
dc.date.application | 2019-03-12 | - |
dc.date.registration | 2023-09-08 | - |
dc.publisher.country | CC | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.